Acetal‐thiol Click‐like Reaction: Facile and Efficient Synthesis of Dynamic Dithioacetals and Recyclable Polydithioacetals DOI

Shuai Du,

Shuaiqi Yang,

Binbo Wang

и другие.

Angewandte Chemie, Год журнала: 2024, Номер 136(31)

Опубликована: Май 20, 2024

Abstract Dithioacetals are heavily used in organic, material and medical chemistries, exhibit huge potential to synthesize degradable or recyclable polymers. However, the current synthetic approaches of dithioacetals polydithioacetals overwhelmingly dependent on external catalysts organic solvents. Herein, we disclose a catalyst‐ solvent‐free acetal‐thiol click‐like reaction for synthesizing polydithioacetals. High conversion, higher than acid catalytic reaction, can be achieved. universality was confirmed by monitoring reactions linear cyclic acetals (including renewable bio‐sourced furan‐acetal) with aliphatic aromatic thiols, mechanism monomolecular nucleophilic substitution (S N 1) auto‐protonation (activation) thiol clarified combining experiments density functional theory computation. Subsequently, utilize this readily By simple heating stirring, w ~110 kDa were synthesized from acetal dithiol, depolymerization into macrocyclic dithioacetal repolymerization polydithioacetal achieved; through reactive extrusion, semi‐interpenetrating polymer dynamic network excellent mechanical properties continuous reprocessability prepared poly(vinyl butyral) pentaerythritol tetrakis(3‐mercaptopropionate). This green high‐efficient synthesis method is beneficial sustainable development chemistry.

Язык: Английский

Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy DOI Creative Commons
Shaomin Yan, Yu Gan, Huizhe Xu

и другие.

Frontiers in Bioengineering and Biotechnology, Год журнала: 2025, Номер 12

Опубликована: Янв. 8, 2025

Cancer is a major killer threatening modern human health and leading cause of death worldwide. Due to the heterogeneity complexity cancer, traditional treatments have limited effectiveness. To address this problem, an increasing number researchers medical professionals are working develop new ways treat cancer. Bacteria chemotaxis that can target colonize tumor tissue, as well activate anti-tumor immune responses, which makes them ideal for biomedical applications. With rapid development nanomedicine synthetic biology technologies, bacteria extensively used carriers drug delivery tumors, holds promise overcoming limitations conventional cancer treatment regimens. This paper summarizes examples anti-cancer drugs delivered by bacterial carriers, their strengths weaknesses. Further, we emphasize carrier systems in clinical translation.

Язык: Английский

Процитировано

2

Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy DOI

Yaofeng Zhou,

Qianying Li, Yuhao Wu

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(21)

Опубликована: Фев. 24, 2024

Engineered bacteria are widely used in cancer treatment because live facultative/obligate anaerobes can selectively proliferate at tumor sites and reach hypoxic regions, thereby causing nutritional competition, enhancing immune responses, producing anticancer microbial agents situ to suppress growth. Despite the unique advantages of bacteria-based biotherapy, insufficient efficiency limits its application complete ablation malignant tumors. The combination nanomedicine engineered has attracted increasing attention owing their striking synergistic effects treatment. that function as natural vehicles effectively deliver nanomedicines sites. Moreover, provide an opportunity enhance by modulating TME substrates support nanomedicine-mediated reactions. Nanomedicine exhibits excellent optical, magnetic, acoustic, catalytic properties, plays important role promoting bacteria-mediated biotherapies. therapy comprehensively summarized this review. Attention is paid not only fabrication nanobiohybrid composites, but also interpromotion mechanism between therapy. Additionally, recent advances bacteria-synergized multimodal therapies highlighted.

Язык: Английский

Процитировано

15

Acetal‐thiol Click‐like Reaction: Facile and Efficient Synthesis of Dynamic Dithioacetals and Recyclable Polydithioacetals DOI

Shuai Du,

Shuaiqi Yang,

Binbo Wang

и другие.

Angewandte Chemie International Edition, Год журнала: 2024, Номер 63(31)

Опубликована: Май 20, 2024

Dithioacetals are heavily used in organic, material and medical chemistries, exhibit huge potential to synthesize degradable or recyclable polymers. However, the current synthetic approaches of dithioacetals polydithioacetals overwhelmingly dependent on external catalysts organic solvents. Herein, we disclose a catalyst- solvent-free acetal-thiol click-like reaction for synthesizing polydithioacetals. High conversion, higher than acid catalytic reaction, can be achieved. universality was confirmed by monitoring reactions linear cyclic acetals (including renewable bio-sourced furan-acetal) with aliphatic aromatic thiols, mechanism monomolecular nucleophilic substitution (S

Язык: Английский

Процитировано

12

Engineering cells for therapy and diagnosis DOI
Zhaoting Li, Yixin Wang, Zhen Gu

и другие.

Nature Reviews Bioengineering, Год журнала: 2024, Номер 2(9), С. 770 - 784

Опубликована: Июнь 19, 2024

Язык: Английский

Процитировано

7

Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease DOI
Pandi Peng, Tao Feng, Xue Yang

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 374, С. 538 - 549

Опубликована: Авг. 30, 2024

Язык: Английский

Процитировано

6

Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis DOI

Yuqin Liu,

Caifang Gao,

Gang� Li

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(25), С. 31950 - 31965

Опубликована: Июнь 11, 2024

Ulcerative colitis (UC) is a recurrent chronic mucosal inflammation disease whose most significant pathological characteristics are intestinal and damaged barrier induced by reactive oxygen/nitrogen species, abnormal immune microenvironment, microecological imbalance. Oral probiotics living therapy for diseases, but their clinical application hindered poor bacterial biological activity insufficient retention. Here, we developed targeted oral formulation, functionalized probiotic Lf@MPB, with Lactobacillus fermentum (Lf) as the core modified melanin nanoparticles (MNPs) on its surface through click reaction of tricarboxyphenylboronic acid synergistic UC. In vitro experiments showed that Lf@MPB not only possessed strong free radical scavenging ability, reduced cellular mitochondrial polarization, inhibited apoptosis also significantly enhanced viability Lf in simulated gastrointestinal fluid. Fluorescence imaging vivo revealed high accumulation at site dextran sulfate sodium-induced UC mice. Moreover, results demonstrated effectively alleviated oxidative stress inflammatory response restored barrier. addition, 16S rRNA gene sequencing verified could increase abundance diversity microbial communities optimize composition to inhibit progression This work combines effective antioxidant anti-inflammatory strategies administration provide promising alternative treatment.

Язык: Английский

Процитировано

5

Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease DOI Creative Commons
Baoxin Zheng,

Liping Wang,

Yan Yi

и другие.

Asian Journal of Pharmaceutical Sciences, Год журнала: 2024, Номер 19(4), С. 100943 - 100943

Опубликована: Июль 14, 2024

Inflammatory bowel diseases (IBD) significantly contribute to high mortality globally and negatively affect patients' qualifications of life. The gastrointestinal tract has unique anatomical characteristics physiological environment limitations. Moreover, certain natural or synthetic anti-inflammatory drugs are associated with poor targeting, low drug accumulation at the lesion site, other side effects, hindering them from exerting their therapeutic effects. Colon-targeted delivery systems represent attractive alternatives as novel carriers for IBD treatment. This review mainly discusses treatment status IBD, obstacles delivery, design strategies colon-targeted systems, perspectives on existing complementary therapies. based recent reports, we summarized mechanism delivery. Finally, addressed challenges future directions facilitate exploitation advanced nanomedicine therapy.

Язык: Английский

Процитировано

5

Lactate/Cysteine Dual-Consuming Probiotic–Nanomedicine Biohybrid System for Enhanced Cancer Chemo-Immunotherapy DOI

Tian‐Qiu Xie,

Xiao Yan,

You‐Teng Qin

и другие.

Nano Letters, Год журнала: 2024, Номер 24(50), С. 16132 - 16142

Опубликована: Дек. 6, 2024

Immunotherapy is revolutionizing oncology, but its therapeutic efficiency still limited by the off-target toxicities and poor antitumor immune responses. By integrating drug-loaded nanoparticles (DMnSH) with unique metabolic traits of Veillonella parvula (Vei), a probiotic–nanomedicine conjugate Vei@DMnSH biohybrid elaborately designed for enhanced cancer chemo-immunotherapy. Specifically, can accumulate in hypoxic tumor sites simultaneously consume lactate cysteine to reverse lactate-associated immunosuppression impede biosynthesis GSH. In addition, DMnSH will rapidly deplete intracellular GSH disassemble release DOX Mn2+. Accompanied two-pronged depletion, Mn2+-mediated Fenton-like reaction effectively generate oxidative hydroxyl radicals induce heavy redox imbalance. Combined effect DOX, robust immunogenic cell death provoked subsequently activates adaptive immunity suppression rate over 82%, synergistically enhancing outcomes

Язык: Английский

Процитировано

5

Tannic acid-based metal-phenolic networks as a versatile platform to mediate cell therapy DOI
Huilong Luo, Juan Xie,

Xiao-Yong Su

и другие.

Science China Materials, Год журнала: 2024, Номер 67(12), С. 3833 - 3848

Опубликована: Ноя. 7, 2024

Язык: Английский

Процитировано

4

Advances in Engineered Bacteria for Cancer Therapy DOI Creative Commons
Wenping Pan, Hongmei Liu, Decheng Wu

и другие.

Precision medicine and engineering., Год журнала: 2025, Номер unknown, С. 100017 - 100017

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0